Detalhe da pesquisa
1.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
N Engl J Med
; 383(22): 2117-2126, 2020 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33196155
2.
Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
Eur Heart J
; 43(41): 4378-4388, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36030400
3.
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Am Heart J
; 231: 128-136, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33045224
4.
In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial.
Vaccine
; 42(3): 496-504, 2024 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38154990
5.
Flipped classroom for learning clinical examination / A sala de aula invertida na aprendizagem do exame clínico
Rev. bras. educ. méd
; 46(1): e010, 2022. tab
Artigo
Inglês
|
LILACS-Express
| ID: biblio-1360845
6.
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: rationale and design of the RIVER trial
Am. heart j
; (231): 128-136, Jan. 2021. tab.
Artigo
Inglês
| SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1145450
7.
Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve
N. Engl. j. med
; 383(22): 1-11, Nov. 2020. graf, tab
Artigo
Inglês
| CONASS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1146447